Eldon C. III Mayer
CIK 1686952 · Ex VP & Chief Commerc. Officer · last filed 2023-03-21
Eldon C. III Mayer is an Ex VP & Chief Commerc. Officer who has filed 25 SEC Form 4 insider transactions across 2 companies since 2016. The most recent filing shows the insider sold $4.7K of EIGR on Mar 21, 2023. Across all open-market trades the lifetime net is +$882.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.42M
2
25
$882.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Ex VP & Chief Commerc. Officer | 56,073 | $1.73 | $96.7K | $275.0K | 16 | 2023-03-21 |
| RIGL | EVP & Chief Commercial Officer | 165,000 | $32.85 | $5.42M | $607.9K | 9 | 2019-11-20 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-21 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Sell (S) | −4,395 | -$4.7K | EDGAR |
| 2023-03-03 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-30 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-14 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Sell (S) | −1,657 | -$9.3K | EDGAR |
| 2022-03-11 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +16,000 | $0 | EDGAR |
| 2022-01-11 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Sell (S) | −1,560 | -$7.7K | EDGAR |
| 2021-07-30 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-15 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +11,875 | $0 | EDGAR |
| 2021-01-11 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Sell (S) | −1,690 | -$19.7K | EDGAR |
| 2020-01-31 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +7,500 | $0 | EDGAR |